Premark Pharma Overview

  • Founded
  • 2018

Founded
  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Premark Pharma General Information

Description

Developer of novel therapeutic drugs designed for the treatment of ophthalmic diseases. The company specializes in the development and commercialization of topical treatments for inflammatory diseases of the skin, eye, mucosae, and mucocutaneous surfaces, enabling doctors to cure patients suffering from unmet conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Christoph Merian-Ring 11
  • 4153 Reinach
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Premark Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 07-Mar-2019 Completed Clinical Trials - Phase 3
To view Premark Pharma’s complete valuation and funding history, request access »

Premark Pharma Patents

Premark Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220218675-A1 Treatment of ocular disease Pending 21-May-2019 0000000000
AU-2020280906-A1 Treatment of ocular disease Pending 21-May-2019 0000000000
CA-3135249-A1 Treatment of ocular disease Pending 21-May-2019 0000000000
EP-3972583-A1 Treatment of ocular disease Pending 21-May-2019 0000000000
EP-3741367-A1 Treatment of ocular disease Inactive 21-May-2019 A61K31/436 00
To view Premark Pharma’s complete patent history, request access »

Premark Pharma Executive Team (1)

Name Title Board Seat Contact Info
Ian Vessey Founder, Board Member, Managing Director & Partner
To view Premark Pharma’s complete executive team members history, request access »

Premark Pharma Board Members (6)

Name Representing Role Since
Brian Hilberdink Premark Pharma Board Member 000 0000
Daniel Parera MD Self Board Member 000 0000
Ian Vessey Premark Pharma Founder, Board Member, Managing Director & Partner 000 0000
Trevor Brown Premark Pharma Chairman 000 0000
William Stewart MD Premark Pharma Board Member & Advisor 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Premark Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
William Stewart Angel (individual) Minority 000 0000 000000 0
To view Premark Pharma’s complete investors history, request access »